These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15065661)

  • 21. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
    Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
    J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RecQ helicases and topoisomerases: implications for genome stability in humans.
    Franchitto A
    Ital J Biochem; 2007 Jun; 56(2):115-21. PubMed ID: 17722652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective pressures at a codon-level predict deleterious mutations in human disease genes.
    Arbiza L; Duchi S; Montaner D; Burguet J; Pantoja-Uceda D; Pineda-Lucena A; Dopazo J; Dopazo H
    J Mol Biol; 2006 May; 358(5):1390-404. PubMed ID: 16584746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mitotic checkpoint in cancer and aging: what have mice taught us?
    Baker DJ; Chen J; van Deursen JM
    Curr Opin Cell Biol; 2005 Dec; 17(6):583-9. PubMed ID: 16226453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives.
    de Moura Gallo CV; Azevedo E Silva Mendonça G; de Moraes E; Olivier M; Hainaut P
    Mutat Res; 2005 May; 589(3):192-207. PubMed ID: 15878142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
    Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P
    Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide association studies for common diseases and complex traits.
    Hirschhorn JN; Daly MJ
    Nat Rev Genet; 2005 Feb; 6(2):95-108. PubMed ID: 15716906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in cancer risk among germline p53 mutation carriers.
    Chompret A; Brugières L; Bonaïti-Pellié C; Feunteun J
    Br J Cancer; 2004 Aug; 91(3):603-4. PubMed ID: 15280910
    [No Abstract]   [Full Text] [Related]  

  • 29. Large common fragile site genes and cancer.
    Smith DI; McAvoy S; Zhu Y; Perez DS
    Semin Cancer Biol; 2007 Feb; 17(1):31-41. PubMed ID: 17140807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the recent evolution of the human genome: insights from human-chimpanzee genome comparisons.
    Kehrer-Sawatzki H; Cooper DN
    Hum Mutat; 2007 Feb; 28(2):99-130. PubMed ID: 17024666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
    Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
    Manoukian S; Peissel B; Pensotti V; Barile M; Cortesi L; Stacchiotti S; Terenziani M; Barbera F; Pasquini G; Frigerio S; Pierotti MA; Radice P; Della-Torre G
    Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53: guardian AND suppressor of longevity?
    Donehower LA
    Exp Gerontol; 2005; 40(1-2):7-9. PubMed ID: 15664727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide functional analysis of human cell-cycle regulators.
    Mukherji M; Bell R; Supekova L; Wang Y; Orth AP; Batalov S; Miraglia L; Huesken D; Lange J; Martin C; Sahasrabudhe S; Reinhardt M; Natt F; Hall J; Mickanin C; Labow M; Chanda SK; Cho CY; Schultz PG
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14819-24. PubMed ID: 17001007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aging: gene silencing or gene activation?
    Burzynski SR
    Med Hypotheses; 2005; 64(1):201-8. PubMed ID: 15533642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.
    Patil A; Hughes AL; Zhang G
    Physiol Genomics; 2004 Dec; 20(1):1-11. PubMed ID: 15494476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of young human genes after a burst of retroposition in primates.
    Marques AC; Dupanloup I; Vinckenbosch N; Reymond A; Kaessmann H
    PLoS Biol; 2005 Nov; 3(11):e357. PubMed ID: 16201836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in high-density whole genome-wide single nucleotide polymorphism array in cancer research].
    Zeng ZY; Xiong W; Zhou YH; Li XL; Li GY
    Ai Zheng; 2006 Nov; 25(11):1454-8. PubMed ID: 17094921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics and human disease: translating basic biology into clinical applications.
    Rodenhiser D; Mann M
    CMAJ; 2006 Jan; 174(3):341-8. PubMed ID: 16446478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.
    Barzon L; Gnatta E; Castagliuolo I; Trevisan M; Moretti F; Pontecorvi A; Boscaro M; Palù G
    Cancer Gene Ther; 2005 Apr; 12(4):381-8. PubMed ID: 15650765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.